Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study

Immune checkpoint inhibitors (ICPIs) agents can cause endocrine immune-related adverse events (irAEs).Aim. Determine the incidence, time of onset and risk factors of endocrine irAEs in cancer patients treated with anti-PD1 and anti-CTLA-4 immunotherapy.Materials and methods. This is a retrospective...

Full description

Bibliographic Details
Main Authors: E. V. Poddubskaya, M. I. Sekacheva, A. A. Guryanova
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2019-12-01
Series:Сеченовский вестник
Subjects:
immune checkpoint inhibitors
hypophysitis
thyroiditis
adrenal insufficiency
diabetes mellitus
adverse effects
Online Access:https://www.sechenovmedj.com/jour/article/view/175

Internet

https://www.sechenovmedj.com/jour/article/view/175

Similar Items